nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—osteoarthritis—Prednisone—prostate cancer	0.39	1	CpDpCtD
Oxaprozin—PTGS2—prostate cancer	0.165	1	CbGaD
Oxaprozin—CYP2C9—Bicalutamide—prostate cancer	0.0484	0.217	CbGbCtD
Oxaprozin—CYP2C9—Nilutamide—prostate cancer	0.0484	0.217	CbGbCtD
Oxaprozin—PTGS2—Etoposide—prostate cancer	0.032	0.143	CbGbCtD
Oxaprozin—CYP2C9—Estrone—prostate cancer	0.029	0.13	CbGbCtD
Oxaprozin—PTGS1—Etoposide—prostate cancer	0.027	0.121	CbGbCtD
Oxaprozin—CYP2C9—Capecitabine—prostate cancer	0.022	0.0984	CbGbCtD
Oxaprozin—CYP2C9—Estradiol—prostate cancer	0.0167	0.0745	CbGbCtD
Oxaprozin—Carbamazepine—RALBP1—prostate cancer	0.00038	0.108	CrCbGaD
Oxaprozin—Bifonazole—CYP17A1—prostate cancer	0.00031	0.0876	CrCbGaD
Oxaprozin—Warfarin—CYP2C18—prostate cancer	0.000208	0.0589	CrCbGaD
Oxaprozin—Bifonazole—CYP19A1—prostate cancer	0.000158	0.0446	CrCbGaD
Oxaprozin—Phenytoin—CYP2C18—prostate cancer	0.000151	0.0428	CrCbGaD
Oxaprozin—Diphenhydramine—CYP2C18—prostate cancer	0.000118	0.0335	CrCbGaD
Oxaprozin—Bifonazole—CYP2E1—prostate cancer	0.000117	0.0332	CrCbGaD
Oxaprozin—Bifonazole—CYP2C19—prostate cancer	0.000116	0.0329	CrCbGaD
Oxaprozin—Methadone—CYP2C18—prostate cancer	0.000114	0.0324	CrCbGaD
Oxaprozin—Modafinil—CYP3A5—prostate cancer	0.000112	0.0318	CrCbGaD
Oxaprozin—Fenbufen—PTGS2—prostate cancer	0.000106	0.0299	CrCbGaD
Oxaprozin—Carbamazepine—CYP3A5—prostate cancer	0.000102	0.029	CrCbGaD
Oxaprozin—Phenytoin—CYP3A5—prostate cancer	9.96e-05	0.0282	CrCbGaD
Oxaprozin—Diphenhydramine—SLC22A1—prostate cancer	9.67e-05	0.0274	CrCbGaD
Oxaprozin—Warfarin—CYP2C19—prostate cancer	9.33e-05	0.0264	CrCbGaD
Oxaprozin—Warfarin—CYP1A1—prostate cancer	9.3e-05	0.0263	CrCbGaD
Oxaprozin—Modafinil—CYP2C19—prostate cancer	7.64e-05	0.0216	CrCbGaD
Oxaprozin—Methadone—CYP3A5—prostate cancer	7.53e-05	0.0213	CrCbGaD
Oxaprozin—Bifonazole—CYP3A4—prostate cancer	7.4e-05	0.0209	CrCbGaD
Oxaprozin—Carbamazepine—CYP2C19—prostate cancer	6.98e-05	0.0197	CrCbGaD
Oxaprozin—Methadone—CYP19A1—prostate cancer	6.94e-05	0.0196	CrCbGaD
Oxaprozin—Phenytoin—CYP2C19—prostate cancer	6.78e-05	0.0192	CrCbGaD
Oxaprozin—Phenprocoumon—CYP3A4—prostate cancer	6.69e-05	0.0189	CrCbGaD
Oxaprozin—Phenylbutazone—CYP3A4—prostate cancer	6.21e-05	0.0176	CrCbGaD
Oxaprozin—Phenylbutazone—PTGS2—prostate cancer	6.08e-05	0.0172	CrCbGaD
Oxaprozin—Warfarin—CYP3A4—prostate cancer	5.94e-05	0.0168	CrCbGaD
Oxaprozin—Propafenone—CYP3A4—prostate cancer	5.8e-05	0.0164	CrCbGaD
Oxaprozin—Confusional state—Docetaxel—prostate cancer	5.46e-05	0.000373	CcSEcCtD
Oxaprozin—Anxiety—Capecitabine—prostate cancer	5.45e-05	0.000372	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—prostate cancer	5.42e-05	0.000371	CcSEcCtD
Oxaprozin—Oedema—Docetaxel—prostate cancer	5.41e-05	0.00037	CcSEcCtD
Oxaprozin—Anaphylactic shock—Docetaxel—prostate cancer	5.41e-05	0.00037	CcSEcCtD
Oxaprozin—Discomfort—Capecitabine—prostate cancer	5.4e-05	0.000369	CcSEcCtD
Oxaprozin—Vision blurred—Prednisone—prostate cancer	5.39e-05	0.000368	CcSEcCtD
Oxaprozin—Infection—Docetaxel—prostate cancer	5.38e-05	0.000367	CcSEcCtD
Oxaprozin—Sinusitis—Epirubicin—prostate cancer	5.37e-05	0.000367	CcSEcCtD
Oxaprozin—Feeling abnormal—Etoposide—prostate cancer	5.37e-05	0.000367	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—prostate cancer	5.36e-05	0.000366	CcSEcCtD
Oxaprozin—Diarrhoea—Mitoxantrone—prostate cancer	5.36e-05	0.000366	CcSEcCtD
Oxaprozin—Dry mouth—Capecitabine—prostate cancer	5.35e-05	0.000365	CcSEcCtD
Oxaprozin—Vomiting—Estradiol—prostate cancer	5.34e-05	0.000365	CcSEcCtD
Oxaprozin—Agranulocytosis—Epirubicin—prostate cancer	5.34e-05	0.000365	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—prostate cancer	5.33e-05	0.000364	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Etoposide—prostate cancer	5.33e-05	0.000364	CcSEcCtD
Oxaprozin—Shock—Docetaxel—prostate cancer	5.33e-05	0.000364	CcSEcCtD
Oxaprozin—Diphenhydramine—CYP2C19—prostate cancer	5.31e-05	0.015	CrCbGaD
Oxaprozin—Ill-defined disorder—Prednisone—prostate cancer	5.31e-05	0.000363	CcSEcCtD
Oxaprozin—Thrombocytopenia—Docetaxel—prostate cancer	5.3e-05	0.000362	CcSEcCtD
Oxaprozin—Rash—Estradiol—prostate cancer	5.3e-05	0.000362	CcSEcCtD
Oxaprozin—Drowsiness—Doxorubicin—prostate cancer	5.3e-05	0.000362	CcSEcCtD
Oxaprozin—Dermatitis—Estradiol—prostate cancer	5.29e-05	0.000362	CcSEcCtD
Oxaprozin—Anaemia—Prednisone—prostate cancer	5.29e-05	0.000361	CcSEcCtD
Oxaprozin—Confusional state—Capecitabine—prostate cancer	5.28e-05	0.000361	CcSEcCtD
Oxaprozin—Tachycardia—Docetaxel—prostate cancer	5.28e-05	0.000361	CcSEcCtD
Oxaprozin—Headache—Estradiol—prostate cancer	5.26e-05	0.00036	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	5.25e-05	0.000359	CcSEcCtD
Oxaprozin—Oedema—Capecitabine—prostate cancer	5.24e-05	0.000358	CcSEcCtD
Oxaprozin—Angioedema—Prednisone—prostate cancer	5.23e-05	0.000357	CcSEcCtD
Oxaprozin—Clorazepate—CYP3A4—prostate cancer	5.22e-05	0.0148	CrCbGaD
Oxaprozin—Renal failure—Doxorubicin—prostate cancer	5.21e-05	0.000356	CcSEcCtD
Oxaprozin—Infection—Capecitabine—prostate cancer	5.21e-05	0.000356	CcSEcCtD
Oxaprozin—Urticaria—Etoposide—prostate cancer	5.17e-05	0.000354	CcSEcCtD
Oxaprozin—Haemoglobin—Epirubicin—prostate cancer	5.16e-05	0.000353	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—prostate cancer	5.16e-05	0.000353	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—prostate cancer	5.16e-05	0.000353	CcSEcCtD
Oxaprozin—Anorexia—Docetaxel—prostate cancer	5.16e-05	0.000353	CcSEcCtD
Oxaprozin—Malaise—Prednisone—prostate cancer	5.16e-05	0.000352	CcSEcCtD
Oxaprozin—Shock—Capecitabine—prostate cancer	5.16e-05	0.000352	CcSEcCtD
Oxaprozin—Abdominal pain—Etoposide—prostate cancer	5.15e-05	0.000352	CcSEcCtD
Oxaprozin—Body temperature increased—Etoposide—prostate cancer	5.15e-05	0.000352	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—prostate cancer	5.15e-05	0.000352	CcSEcCtD
Oxaprozin—Vertigo—Prednisone—prostate cancer	5.14e-05	0.000351	CcSEcCtD
Oxaprozin—Haemorrhage—Epirubicin—prostate cancer	5.14e-05	0.000351	CcSEcCtD
Oxaprozin—Hepatitis—Epirubicin—prostate cancer	5.14e-05	0.000351	CcSEcCtD
Oxaprozin—Thrombocytopenia—Capecitabine—prostate cancer	5.13e-05	0.000351	CcSEcCtD
Oxaprozin—Syncope—Prednisone—prostate cancer	5.13e-05	0.000351	CcSEcCtD
Oxaprozin—Methadone—CYP2C19—prostate cancer	5.13e-05	0.0145	CrCbGaD
Oxaprozin—Tachycardia—Capecitabine—prostate cancer	5.11e-05	0.00035	CcSEcCtD
Oxaprozin—Hyperhidrosis—Capecitabine—prostate cancer	5.07e-05	0.000346	CcSEcCtD
Oxaprozin—Hypotension—Docetaxel—prostate cancer	5.06e-05	0.000346	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—prostate cancer	5.05e-05	0.000345	CcSEcCtD
Oxaprozin—Loss of consciousness—Prednisone—prostate cancer	5.03e-05	0.000344	CcSEcCtD
Oxaprozin—Anorexia—Capecitabine—prostate cancer	5e-05	0.000341	CcSEcCtD
Oxaprozin—Nausea—Estradiol—prostate cancer	4.99e-05	0.000341	CcSEcCtD
Oxaprozin—Vomiting—Mitoxantrone—prostate cancer	4.98e-05	0.00034	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—prostate cancer	4.97e-05	0.00034	CcSEcCtD
Oxaprozin—Flurbiprofen—PTGS2—prostate cancer	4.96e-05	0.014	CrCbGaD
Oxaprozin—Convulsion—Prednisone—prostate cancer	4.96e-05	0.000339	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—prostate cancer	4.94e-05	0.000338	CcSEcCtD
Oxaprozin—Hypertension—Prednisone—prostate cancer	4.94e-05	0.000337	CcSEcCtD
Oxaprozin—Rash—Mitoxantrone—prostate cancer	4.94e-05	0.000337	CcSEcCtD
Oxaprozin—Dermatitis—Mitoxantrone—prostate cancer	4.93e-05	0.000337	CcSEcCtD
Oxaprozin—Headache—Mitoxantrone—prostate cancer	4.91e-05	0.000335	CcSEcCtD
Oxaprozin—Hypotension—Capecitabine—prostate cancer	4.9e-05	0.000335	CcSEcCtD
Oxaprozin—Insomnia—Docetaxel—prostate cancer	4.9e-05	0.000335	CcSEcCtD
Oxaprozin—Modafinil—CYP3A4—prostate cancer	4.86e-05	0.0138	CrCbGaD
Oxaprozin—Paraesthesia—Docetaxel—prostate cancer	4.86e-05	0.000332	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—prostate cancer	4.86e-05	0.000332	CcSEcCtD
Oxaprozin—Anxiety—Prednisone—prostate cancer	4.85e-05	0.000332	CcSEcCtD
Oxaprozin—Dyspnoea—Docetaxel—prostate cancer	4.83e-05	0.00033	CcSEcCtD
Oxaprozin—Somnolence—Docetaxel—prostate cancer	4.81e-05	0.000329	CcSEcCtD
Oxaprozin—Discomfort—Prednisone—prostate cancer	4.81e-05	0.000329	CcSEcCtD
Oxaprozin—Tinnitus—Epirubicin—prostate cancer	4.79e-05	0.000327	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—prostate cancer	4.78e-05	0.000327	CcSEcCtD
Oxaprozin—Dyspepsia—Docetaxel—prostate cancer	4.76e-05	0.000326	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—prostate cancer	4.75e-05	0.000325	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—prostate cancer	4.75e-05	0.000325	CcSEcCtD
Oxaprozin—Insomnia—Capecitabine—prostate cancer	4.74e-05	0.000324	CcSEcCtD
Oxaprozin—Paraesthesia—Capecitabine—prostate cancer	4.71e-05	0.000322	CcSEcCtD
Oxaprozin—Decreased appetite—Docetaxel—prostate cancer	4.71e-05	0.000322	CcSEcCtD
Oxaprozin—Asthenia—Etoposide—prostate cancer	4.67e-05	0.000319	CcSEcCtD
Oxaprozin—Dyspnoea—Capecitabine—prostate cancer	4.67e-05	0.000319	CcSEcCtD
Oxaprozin—Anaphylactic shock—Prednisone—prostate cancer	4.67e-05	0.000319	CcSEcCtD
Oxaprozin—Oedema—Prednisone—prostate cancer	4.67e-05	0.000319	CcSEcCtD
Oxaprozin—Nausea—Mitoxantrone—prostate cancer	4.65e-05	0.000318	CcSEcCtD
Oxaprozin—Infection—Prednisone—prostate cancer	4.64e-05	0.000317	CcSEcCtD
Oxaprozin—Constipation—Docetaxel—prostate cancer	4.63e-05	0.000316	CcSEcCtD
Oxaprozin—Dyspepsia—Capecitabine—prostate cancer	4.61e-05	0.000315	CcSEcCtD
Oxaprozin—Pruritus—Etoposide—prostate cancer	4.61e-05	0.000315	CcSEcCtD
Oxaprozin—Shock—Prednisone—prostate cancer	4.59e-05	0.000314	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—prostate cancer	4.59e-05	0.000314	CcSEcCtD
Oxaprozin—Tachycardia—Prednisone—prostate cancer	4.56e-05	0.000311	CcSEcCtD
Oxaprozin—Decreased appetite—Capecitabine—prostate cancer	4.56e-05	0.000311	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—prostate cancer	4.54e-05	0.00031	CcSEcCtD
Oxaprozin—Hyperhidrosis—Prednisone—prostate cancer	4.51e-05	0.000308	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—prostate cancer	4.5e-05	0.000307	CcSEcCtD
Oxaprozin—Constipation—Capecitabine—prostate cancer	4.48e-05	0.000306	CcSEcCtD
Oxaprozin—Feeling abnormal—Docetaxel—prostate cancer	4.46e-05	0.000305	CcSEcCtD
Oxaprozin—Diarrhoea—Etoposide—prostate cancer	4.46e-05	0.000305	CcSEcCtD
Oxaprozin—Anorexia—Prednisone—prostate cancer	4.45e-05	0.000304	CcSEcCtD
Oxaprozin—Carbamazepine—CYP3A4—prostate cancer	4.44e-05	0.0126	CrCbGaD
Oxaprozin—Tinnitus—Doxorubicin—prostate cancer	4.43e-05	0.000303	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Docetaxel—prostate cancer	4.43e-05	0.000302	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—prostate cancer	4.41e-05	0.000301	CcSEcCtD
Oxaprozin—Tension—Epirubicin—prostate cancer	4.39e-05	0.0003	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—prostate cancer	4.38e-05	0.000299	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—prostate cancer	4.34e-05	0.000297	CcSEcCtD
Oxaprozin—Feeling abnormal—Capecitabine—prostate cancer	4.32e-05	0.000295	CcSEcCtD
Oxaprozin—Phenytoin—CYP3A4—prostate cancer	4.31e-05	0.0122	CrCbGaD
Oxaprozin—Dizziness—Etoposide—prostate cancer	4.31e-05	0.000294	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Capecitabine—prostate cancer	4.29e-05	0.000293	CcSEcCtD
Oxaprozin—Abdominal pain—Docetaxel—prostate cancer	4.28e-05	0.000292	CcSEcCtD
Oxaprozin—Body temperature increased—Docetaxel—prostate cancer	4.28e-05	0.000292	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—prostate cancer	4.25e-05	0.00029	CcSEcCtD
Oxaprozin—Insomnia—Prednisone—prostate cancer	4.22e-05	0.000289	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—prostate cancer	4.22e-05	0.000288	CcSEcCtD
Oxaprozin—Benzphetamine—CYP3A4—prostate cancer	4.21e-05	0.0119	CrCbGaD
Oxaprozin—Alopecia—Doxorubicin—prostate cancer	4.2e-05	0.000287	CcSEcCtD
Oxaprozin—Paraesthesia—Prednisone—prostate cancer	4.19e-05	0.000286	CcSEcCtD
Oxaprozin—Urticaria—Capecitabine—prostate cancer	4.16e-05	0.000284	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—prostate cancer	4.15e-05	0.000284	CcSEcCtD
Oxaprozin—Abdominal pain—Capecitabine—prostate cancer	4.14e-05	0.000283	CcSEcCtD
Oxaprozin—Body temperature increased—Capecitabine—prostate cancer	4.14e-05	0.000283	CcSEcCtD
Oxaprozin—Vomiting—Etoposide—prostate cancer	4.14e-05	0.000283	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—prostate cancer	4.13e-05	0.000283	CcSEcCtD
Oxaprozin—Dyspepsia—Prednisone—prostate cancer	4.11e-05	0.000281	CcSEcCtD
Oxaprozin—Rash—Etoposide—prostate cancer	4.11e-05	0.000281	CcSEcCtD
Oxaprozin—Dermatitis—Etoposide—prostate cancer	4.1e-05	0.00028	CcSEcCtD
Oxaprozin—Headache—Etoposide—prostate cancer	4.08e-05	0.000279	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—prostate cancer	4.08e-05	0.000279	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—prostate cancer	4.06e-05	0.000278	CcSEcCtD
Oxaprozin—Decreased appetite—Prednisone—prostate cancer	4.06e-05	0.000277	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—prostate cancer	4.05e-05	0.000277	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—prostate cancer	4.03e-05	0.000276	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—prostate cancer	4.02e-05	0.000275	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—prostate cancer	4.02e-05	0.000275	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—prostate cancer	4.01e-05	0.000274	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—prostate cancer	4e-05	0.000274	CcSEcCtD
Oxaprozin—Constipation—Prednisone—prostate cancer	3.99e-05	0.000273	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—prostate cancer	3.95e-05	0.00027	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—prostate cancer	3.93e-05	0.000269	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—prostate cancer	3.9e-05	0.000267	CcSEcCtD
Oxaprozin—Asthenia—Docetaxel—prostate cancer	3.88e-05	0.000265	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—prostate cancer	3.88e-05	0.000265	CcSEcCtD
Oxaprozin—Nausea—Etoposide—prostate cancer	3.87e-05	0.000264	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—prostate cancer	3.86e-05	0.000264	CcSEcCtD
Oxaprozin—Feeling abnormal—Prednisone—prostate cancer	3.85e-05	0.000263	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—prostate cancer	3.84e-05	0.000262	CcSEcCtD
Oxaprozin—Pruritus—Docetaxel—prostate cancer	3.83e-05	0.000262	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—prostate cancer	3.83e-05	0.000261	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Prednisone—prostate cancer	3.82e-05	0.000261	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—prostate cancer	3.8e-05	0.000259	CcSEcCtD
Oxaprozin—Discomfort—Epirubicin—prostate cancer	3.76e-05	0.000257	CcSEcCtD
Oxaprozin—Asthenia—Capecitabine—prostate cancer	3.76e-05	0.000257	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—prostate cancer	3.73e-05	0.000255	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—prostate cancer	3.72e-05	0.000255	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—prostate cancer	3.72e-05	0.000254	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—prostate cancer	3.71e-05	0.000254	CcSEcCtD
Oxaprozin—Urticaria—Prednisone—prostate cancer	3.71e-05	0.000253	CcSEcCtD
Oxaprozin—Pruritus—Capecitabine—prostate cancer	3.71e-05	0.000253	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—prostate cancer	3.7e-05	0.000253	CcSEcCtD
Oxaprozin—Diarrhoea—Docetaxel—prostate cancer	3.7e-05	0.000253	CcSEcCtD
Oxaprozin—Body temperature increased—Prednisone—prostate cancer	3.69e-05	0.000252	CcSEcCtD
Oxaprozin—Abdominal pain—Prednisone—prostate cancer	3.69e-05	0.000252	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—prostate cancer	3.68e-05	0.000252	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—prostate cancer	3.66e-05	0.00025	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—prostate cancer	3.65e-05	0.000249	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—prostate cancer	3.65e-05	0.000249	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—prostate cancer	3.64e-05	0.000249	CcSEcCtD
Oxaprozin—Infection—Epirubicin—prostate cancer	3.63e-05	0.000248	CcSEcCtD
Oxaprozin—Shock—Epirubicin—prostate cancer	3.59e-05	0.000245	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—prostate cancer	3.59e-05	0.000245	CcSEcCtD
Oxaprozin—Diarrhoea—Capecitabine—prostate cancer	3.59e-05	0.000245	CcSEcCtD
Oxaprozin—Dizziness—Docetaxel—prostate cancer	3.58e-05	0.000245	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—prostate cancer	3.57e-05	0.000244	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—prostate cancer	3.57e-05	0.000244	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—prostate cancer	3.56e-05	0.000243	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—prostate cancer	3.53e-05	0.000241	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—prostate cancer	3.51e-05	0.00024	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—prostate cancer	3.48e-05	0.000238	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—prostate cancer	3.48e-05	0.000238	CcSEcCtD
Oxaprozin—Dizziness—Capecitabine—prostate cancer	3.47e-05	0.000237	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—prostate cancer	3.45e-05	0.000236	CcSEcCtD
Oxaprozin—Vomiting—Docetaxel—prostate cancer	3.44e-05	0.000235	CcSEcCtD
Oxaprozin—Rash—Docetaxel—prostate cancer	3.41e-05	0.000233	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—prostate cancer	3.41e-05	0.000233	CcSEcCtD
Oxaprozin—Dermatitis—Docetaxel—prostate cancer	3.41e-05	0.000233	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—prostate cancer	3.41e-05	0.000233	CcSEcCtD
Oxaprozin—Headache—Docetaxel—prostate cancer	3.39e-05	0.000232	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—prostate cancer	3.38e-05	0.000231	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—prostate cancer	3.38e-05	0.000231	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—prostate cancer	3.36e-05	0.000229	CcSEcCtD
Oxaprozin—Asthenia—Prednisone—prostate cancer	3.35e-05	0.000229	CcSEcCtD
Oxaprozin—Vomiting—Capecitabine—prostate cancer	3.33e-05	0.000228	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—prostate cancer	3.32e-05	0.000227	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—prostate cancer	3.31e-05	0.000226	CcSEcCtD
Oxaprozin—Rash—Capecitabine—prostate cancer	3.3e-05	0.000226	CcSEcCtD
Oxaprozin—Pruritus—Prednisone—prostate cancer	3.3e-05	0.000226	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—prostate cancer	3.3e-05	0.000226	CcSEcCtD
Oxaprozin—Dermatitis—Capecitabine—prostate cancer	3.3e-05	0.000226	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—prostate cancer	3.3e-05	0.000225	CcSEcCtD
Oxaprozin—Headache—Capecitabine—prostate cancer	3.28e-05	0.000224	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—prostate cancer	3.28e-05	0.000224	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—prostate cancer	3.27e-05	0.000223	CcSEcCtD
Oxaprozin—Methadone—CYP3A4—prostate cancer	3.26e-05	0.00923	CrCbGaD
Oxaprozin—Dyspnoea—Epirubicin—prostate cancer	3.25e-05	0.000222	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—prostate cancer	3.25e-05	0.000222	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—prostate cancer	3.22e-05	0.00022	CcSEcCtD
Oxaprozin—Nausea—Docetaxel—prostate cancer	3.22e-05	0.00022	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—prostate cancer	3.21e-05	0.00022	CcSEcCtD
Oxaprozin—Diarrhoea—Prednisone—prostate cancer	3.19e-05	0.000218	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—prostate cancer	3.17e-05	0.000217	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—prostate cancer	3.16e-05	0.000216	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—prostate cancer	3.12e-05	0.000213	CcSEcCtD
Oxaprozin—Nausea—Capecitabine—prostate cancer	3.11e-05	0.000213	CcSEcCtD
Oxaprozin—Dizziness—Prednisone—prostate cancer	3.09e-05	0.000211	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—prostate cancer	3.06e-05	0.000209	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—prostate cancer	3.03e-05	0.000207	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—prostate cancer	3.01e-05	0.000206	CcSEcCtD
Oxaprozin—Feeling abnormal—Epirubicin—prostate cancer	3.01e-05	0.000206	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—prostate cancer	3e-05	0.000205	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Epirubicin—prostate cancer	2.99e-05	0.000204	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—prostate cancer	2.97e-05	0.000203	CcSEcCtD
Oxaprozin—Vomiting—Prednisone—prostate cancer	2.97e-05	0.000203	CcSEcCtD
Oxaprozin—Rash—Prednisone—prostate cancer	2.94e-05	0.000201	CcSEcCtD
Oxaprozin—Dermatitis—Prednisone—prostate cancer	2.94e-05	0.000201	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—prostate cancer	2.94e-05	0.000201	CcSEcCtD
Oxaprozin—Headache—Prednisone—prostate cancer	2.92e-05	0.0002	CcSEcCtD
Oxaprozin—Urticaria—Epirubicin—prostate cancer	2.9e-05	0.000198	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—prostate cancer	2.89e-05	0.000197	CcSEcCtD
Oxaprozin—Abdominal pain—Epirubicin—prostate cancer	2.89e-05	0.000197	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—prostate cancer	2.89e-05	0.000197	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—prostate cancer	2.78e-05	0.00019	CcSEcCtD
Oxaprozin—Nausea—Prednisone—prostate cancer	2.77e-05	0.000189	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—prostate cancer	2.76e-05	0.000189	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—prostate cancer	2.68e-05	0.000183	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—prostate cancer	2.67e-05	0.000182	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—prostate cancer	2.67e-05	0.000182	CcSEcCtD
Oxaprozin—Asthenia—Epirubicin—prostate cancer	2.62e-05	0.000179	CcSEcCtD
Oxaprozin—Pruritus—Epirubicin—prostate cancer	2.58e-05	0.000177	CcSEcCtD
Oxaprozin—Diarrhoea—Epirubicin—prostate cancer	2.5e-05	0.000171	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—prostate cancer	2.42e-05	0.000166	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—prostate cancer	2.41e-05	0.000165	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—prostate cancer	2.39e-05	0.000163	CcSEcCtD
Oxaprozin—Vomiting—Epirubicin—prostate cancer	2.32e-05	0.000159	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—prostate cancer	2.31e-05	0.000158	CcSEcCtD
Oxaprozin—Rash—Epirubicin—prostate cancer	2.3e-05	0.000157	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—prostate cancer	2.3e-05	0.000157	CcSEcCtD
Oxaprozin—Headache—Epirubicin—prostate cancer	2.29e-05	0.000156	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—prostate cancer	2.23e-05	0.000153	CcSEcCtD
Oxaprozin—Nausea—Epirubicin—prostate cancer	2.17e-05	0.000148	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—prostate cancer	2.15e-05	0.000147	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—prostate cancer	2.13e-05	0.000146	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—prostate cancer	2.13e-05	0.000145	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—prostate cancer	2.12e-05	0.000145	CcSEcCtD
Oxaprozin—Nausea—Doxorubicin—prostate cancer	2.01e-05	0.000137	CcSEcCtD
Oxaprozin—CYP2C9—urine—prostate cancer	1.53e-05	0.262	CbGeAlD
Oxaprozin—PTGS2—Metabolism—LRP2—prostate cancer	1.24e-05	0.000174	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2C18—prostate cancer	1.24e-05	0.000174	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—P4HB—prostate cancer	1.22e-05	0.00017	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP7B1—prostate cancer	1.22e-05	0.00017	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTAP—prostate cancer	1.22e-05	0.00017	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKR1C3—prostate cancer	1.22e-05	0.00017	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PRKACB—prostate cancer	1.21e-05	0.000169	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP17A1—prostate cancer	1.2e-05	0.000167	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.19e-05	0.000167	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.19e-05	0.000166	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SRD5A1—prostate cancer	1.19e-05	0.000166	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SULT1E1—prostate cancer	1.19e-05	0.000166	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC22A1—prostate cancer	1.18e-05	0.000166	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.18e-05	0.000165	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFBR1—prostate cancer	1.17e-05	0.000164	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—B2M—prostate cancer	1.17e-05	0.000164	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.17e-05	0.000164	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SULT2A1—prostate cancer	1.15e-05	0.000161	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.15e-05	0.000161	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPS19—prostate cancer	1.15e-05	0.000161	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKR1C3—prostate cancer	1.15e-05	0.000161	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.15e-05	0.000161	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRKACB—prostate cancer	1.15e-05	0.00016	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOA2—prostate cancer	1.14e-05	0.00016	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MED12—prostate cancer	1.14e-05	0.000159	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.14e-05	0.000159	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ACSL4—prostate cancer	1.13e-05	0.000158	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HSD17B3—prostate cancer	1.13e-05	0.000158	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GNG5—prostate cancer	1.13e-05	0.000158	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.12e-05	0.000156	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PPP3CA—prostate cancer	1.12e-05	0.000156	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC5A5—prostate cancer	1.09e-05	0.000152	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOA3—prostate cancer	1.09e-05	0.000152	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PHGDH—prostate cancer	1.09e-05	0.000152	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—UMPS—prostate cancer	1.09e-05	0.000152	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ARG2—prostate cancer	1.09e-05	0.000152	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRKCZ—prostate cancer	1.08e-05	0.000151	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.08e-05	0.000151	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.07e-05	0.000149	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LDHB—prostate cancer	1.06e-05	0.000149	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP2E1—prostate cancer	1.06e-05	0.000149	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CALR—prostate cancer	1.06e-05	0.000149	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NQO1—prostate cancer	1.05e-05	0.000147	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PARP1—prostate cancer	1.04e-05	0.000146	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGFR4—prostate cancer	1.04e-05	0.000146	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP3A5—prostate cancer	1.04e-05	0.000146	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TH—prostate cancer	1.04e-05	0.000145	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HPGDS—prostate cancer	1.04e-05	0.000145	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CALCA—prostate cancer	1.03e-05	0.000144	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.03e-05	0.000144	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2C19—prostate cancer	1.03e-05	0.000144	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP3A4—prostate cancer	1.03e-05	0.000143	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.02e-05	0.000143	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PDHA1—prostate cancer	1.01e-05	0.000141	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—UCP3—prostate cancer	1.01e-05	0.000141	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA3—prostate cancer	1.01e-05	0.000141	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TCN2—prostate cancer	1.01e-05	0.000141	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP1B1—prostate cancer	1.01e-05	0.000141	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ACHE—prostate cancer	1e-05	0.00014	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTT1—prostate cancer	1e-05	0.00014	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2A6—prostate cancer	9.93e-06	0.000139	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HSPA1A—prostate cancer	9.89e-06	0.000138	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	9.89e-06	0.000138	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GGT1—prostate cancer	9.76e-06	0.000137	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	9.75e-06	0.000136	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKR1C3—prostate cancer	9.66e-06	0.000135	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HSD3B1—prostate cancer	9.62e-06	0.000135	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC22A3—prostate cancer	9.62e-06	0.000135	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOA1—prostate cancer	9.62e-06	0.000134	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PRKACB—prostate cancer	9.61e-06	0.000134	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP17A1—prostate cancer	9.51e-06	0.000133	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CASP9—prostate cancer	9.49e-06	0.000133	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP19A1—prostate cancer	9.48e-06	0.000133	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.38e-06	0.000131	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	9.34e-06	0.000131	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TBXAS1—prostate cancer	9.23e-06	0.000129	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA4—prostate cancer	9.23e-06	0.000129	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRKCQ—prostate cancer	9.2e-06	0.000129	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—RXRA—prostate cancer	9.15e-06	0.000128	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOA2—prostate cancer	9.06e-06	0.000127	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	9.02e-06	0.000126	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA2—prostate cancer	8.99e-06	0.000126	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.9e-06	0.000124	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SULT1A1—prostate cancer	8.88e-06	0.000124	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCG5—prostate cancer	8.88e-06	0.000124	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—COMT—prostate cancer	8.81e-06	0.000123	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTP1—prostate cancer	8.77e-06	0.000123	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF10—prostate cancer	8.74e-06	0.000122	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA1—prostate cancer	8.68e-06	0.000121	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC5A5—prostate cancer	8.64e-06	0.000121	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ITPR1—prostate cancer	8.63e-06	0.000121	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTO1—prostate cancer	8.58e-06	0.00012	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HSD3B2—prostate cancer	8.58e-06	0.00012	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NAT2—prostate cancer	8.58e-06	0.00012	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.49e-06	0.000119	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2E1—prostate cancer	8.44e-06	0.000118	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NQO1—prostate cancer	8.35e-06	0.000117	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFBR2—prostate cancer	8.31e-06	0.000116	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.25e-06	0.000115	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TH—prostate cancer	8.23e-06	0.000115	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLCB2—prostate cancer	8.22e-06	0.000115	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LRP2—prostate cancer	8.22e-06	0.000115	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2C18—prostate cancer	8.22e-06	0.000115	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ITPR1—prostate cancer	8.18e-06	0.000114	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.17e-06	0.000114	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TYMS—prostate cancer	8.15e-06	0.000114	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP3A4—prostate cancer	8.14e-06	0.000114	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—P4HB—prostate cancer	8.07e-06	0.000113	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM1—prostate cancer	8.06e-06	0.000113	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP1B1—prostate cancer	8e-06	0.000112	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LPL—prostate cancer	7.91e-06	0.000111	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC22A1—prostate cancer	7.85e-06	0.00011	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.76e-06	0.000108	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GGT1—prostate cancer	7.75e-06	0.000108	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SULT2A1—prostate cancer	7.65e-06	0.000107	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP1A1—prostate cancer	7.64e-06	0.000107	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOA1—prostate cancer	7.63e-06	0.000107	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ERCC2—prostate cancer	7.58e-06	0.000106	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP19A1—prostate cancer	7.52e-06	0.000105	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MED12—prostate cancer	7.52e-06	0.000105	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—LPL—prostate cancer	7.5e-06	0.000105	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GNG5—prostate cancer	7.46e-06	0.000104	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFRB—prostate cancer	7.43e-06	0.000104	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—RXRA—prostate cancer	7.26e-06	0.000102	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOA3—prostate cancer	7.19e-06	0.000101	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERCC2—prostate cancer	7.18e-06	0.0001	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTHFR—prostate cancer	7.12e-06	9.96e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.06e-06	9.88e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.06e-06	9.87e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB3—prostate cancer	7.03e-06	9.82e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGFR2—prostate cancer	7.01e-06	9.81e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—COMT—prostate cancer	7e-06	9.78e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PPARA—prostate cancer	6.99e-06	9.77e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTP1—prostate cancer	6.96e-06	9.73e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HPGDS—prostate cancer	6.86e-06	9.59e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ITPR1—prostate cancer	6.85e-06	9.58e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2C19—prostate cancer	6.82e-06	9.53e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTHFR—prostate cancer	6.75e-06	9.44e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.74e-06	9.42e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TERT—prostate cancer	6.73e-06	9.41e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTT1—prostate cancer	6.65e-06	9.3e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ACHE—prostate cancer	6.65e-06	9.3e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2A6—prostate cancer	6.58e-06	9.19e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CAV1—prostate cancer	6.57e-06	9.19e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.55e-06	9.16e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TYMS—prostate cancer	6.47e-06	9.05e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HIF1A—prostate cancer	6.44e-06	9e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM1—prostate cancer	6.4e-06	8.94e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKR1C3—prostate cancer	6.4e-06	8.94e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PRKACB—prostate cancer	6.36e-06	8.89e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP17A1—prostate cancer	6.3e-06	8.8e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LPL—prostate cancer	6.28e-06	8.78e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.28e-06	8.78e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CAV1—prostate cancer	6.23e-06	8.71e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.21e-06	8.68e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP1A1—prostate cancer	6.07e-06	8.48e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ERCC2—prostate cancer	6.02e-06	8.41e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOA2—prostate cancer	6e-06	8.39e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CG—prostate cancer	5.98e-06	8.37e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BAD—prostate cancer	5.86e-06	8.19e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC5A5—prostate cancer	5.72e-06	8e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APC—prostate cancer	5.67e-06	7.93e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—INS—prostate cancer	5.66e-06	7.92e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTHFR—prostate cancer	5.65e-06	7.91e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IRS1—prostate cancer	5.61e-06	7.84e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGF—prostate cancer	5.61e-06	7.84e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2E1—prostate cancer	5.59e-06	7.82e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CREBBP—prostate cancer	5.55e-06	7.76e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPARA—prostate cancer	5.55e-06	7.76e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NQO1—prostate cancer	5.53e-06	7.73e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TH—prostate cancer	5.45e-06	7.62e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GSK3B—prostate cancer	5.44e-06	7.61e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.41e-06	7.57e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP3A4—prostate cancer	5.39e-06	7.54e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—INS—prostate cancer	5.37e-06	7.51e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.36e-06	7.5e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP1B1—prostate cancer	5.3e-06	7.41e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CD—prostate cancer	5.26e-06	7.36e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CREBBP—prostate cancer	5.26e-06	7.35e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CAV1—prostate cancer	5.22e-06	7.29e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GGT1—prostate cancer	5.13e-06	7.18e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOA1—prostate cancer	5.06e-06	7.07e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAP2K1—prostate cancer	5.02e-06	7.02e-05	CbGpPWpGaD
Oxaprozin—PTGS1—prostate gland—prostate cancer	5.02e-06	0.086	CbGeAlD
Oxaprozin—PTGS2—Disease—PIK3CD—prostate cancer	4.99e-06	6.97e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP19A1—prostate cancer	4.98e-06	6.97e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.98e-06	6.97e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NOS3—prostate cancer	4.97e-06	6.95e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SERPINE1—prostate cancer	4.93e-06	6.9e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—RXRA—prostate cancer	4.81e-06	6.72e-05	CbGpPWpGaD
Oxaprozin—PTGS2—prostate gland—prostate cancer	4.8e-06	0.0822	CbGeAlD
Oxaprozin—PTGS2—Disease—FGF2—prostate cancer	4.77e-06	6.68e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CG—prostate cancer	4.75e-06	6.64e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOS3—prostate cancer	4.71e-06	6.58e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.68e-06	6.54e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—COMT—prostate cancer	4.63e-06	6.48e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTP1—prostate cancer	4.61e-06	6.45e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CB—prostate cancer	4.59e-06	6.41e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—JAK2—prostate cancer	4.58e-06	6.4e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTGS2—prostate cancer	4.54e-06	6.35e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ITPR1—prostate cancer	4.54e-06	6.34e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—INS—prostate cancer	4.5e-06	6.29e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MDM2—prostate cancer	4.47e-06	6.25e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.46e-06	6.24e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CREBBP—prostate cancer	4.4e-06	6.16e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB2—prostate cancer	4.4e-06	6.16e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CB—prostate cancer	4.35e-06	6.08e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TYMS—prostate cancer	4.29e-06	5.99e-05	CbGpPWpGaD
Oxaprozin—PTGS1—seminal vesicle—prostate cancer	4.25e-06	0.0727	CbGeAlD
Oxaprozin—CYP2C9—Metabolism—GSTM1—prostate cancer	4.24e-06	5.92e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CD—prostate cancer	4.18e-06	5.84e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LPL—prostate cancer	4.16e-06	5.81e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1B—prostate cancer	4.08e-06	5.7e-05	CbGpPWpGaD
Oxaprozin—PTGS2—seminal vesicle—prostate cancer	4.06e-06	0.0695	CbGeAlD
Oxaprozin—CYP2C9—Metabolism—CYP1A1—prostate cancer	4.02e-06	5.62e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ERCC2—prostate cancer	3.98e-06	5.57e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTEN—prostate cancer	3.96e-06	5.54e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NOS3—prostate cancer	3.94e-06	5.51e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CTNNB1—prostate cancer	3.85e-06	5.39e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—EP300—prostate cancer	3.78e-06	5.28e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1A—prostate cancer	3.76e-06	5.26e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTEN—prostate cancer	3.76e-06	5.25e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTHFR—prostate cancer	3.74e-06	5.23e-05	CbGpPWpGaD
Oxaprozin—PTGS1—epithelium—prostate cancer	3.69e-06	0.0632	CbGeAlD
Oxaprozin—CYP2C9—Metabolism—PPARA—prostate cancer	3.67e-06	5.14e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CB—prostate cancer	3.64e-06	5.09e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EP300—prostate cancer	3.58e-06	5.01e-05	CbGpPWpGaD
Oxaprozin—PTGS2—epithelium—prostate cancer	3.53e-06	0.0604	CbGeAlD
Oxaprozin—PTGS2—Disease—SRC—prostate cancer	3.48e-06	4.87e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CAV1—prostate cancer	3.45e-06	4.83e-05	CbGpPWpGaD
Oxaprozin—PTGS1—renal system—prostate cancer	3.42e-06	0.0586	CbGeAlD
Oxaprozin—PTGS2—Disease—STAT3—prostate cancer	3.36e-06	4.7e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.3e-06	4.61e-05	CbGpPWpGaD
Oxaprozin—PTGS2—renal system—prostate cancer	3.27e-06	0.056	CbGeAlD
Oxaprozin—PTGS2—urethra—prostate cancer	3.21e-06	0.055	CbGeAlD
Oxaprozin—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.15e-06	4.4e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTEN—prostate cancer	3.15e-06	4.4e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—prostate cancer	3.12e-06	4.36e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFB1—prostate cancer	3.11e-06	4.35e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGFR—prostate cancer	3.05e-06	4.27e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—EP300—prostate cancer	3e-06	4.19e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—INS—prostate cancer	2.98e-06	4.16e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CREBBP—prostate cancer	2.92e-06	4.08e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KRAS—prostate cancer	2.88e-06	4.03e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CA—prostate cancer	2.8e-06	3.91e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.77e-06	3.87e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CA—prostate cancer	2.65e-06	3.7e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NOS3—prostate cancer	2.61e-06	3.65e-05	CbGpPWpGaD
Oxaprozin—PTGS2—bone marrow—prostate cancer	2.47e-06	0.0424	CbGeAlD
Oxaprozin—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.41e-06	3.37e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS2—prostate cancer	2.39e-06	3.34e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—prostate cancer	2.35e-06	3.28e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKT1—prostate cancer	2.28e-06	3.19e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CA—prostate cancer	2.22e-06	3.1e-05	CbGpPWpGaD
Oxaprozin—PTGS1—testis—prostate cancer	2.21e-06	0.0379	CbGeAlD
Oxaprozin—PTGS2—Disease—AKT1—prostate cancer	2.16e-06	3.03e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTEN—prostate cancer	2.08e-06	2.91e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—EP300—prostate cancer	1.99e-06	2.78e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKT1—prostate cancer	1.81e-06	2.53e-05	CbGpPWpGaD
Oxaprozin—PTGS1—lymph node—prostate cancer	1.6e-06	0.0275	CbGeAlD
Oxaprozin—PTGS2—lymph node—prostate cancer	1.53e-06	0.0262	CbGeAlD
Oxaprozin—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.47e-06	2.05e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKT1—prostate cancer	1.2e-06	1.68e-05	CbGpPWpGaD
